Biovail 'disappointed' by clinical trial of drug to treat Parkinson's psychosis

TORONTO - Disappointing results from a clinical trial for a drug aimed at patients with Parkinsons's disease psychosis sent shares of Biovail Corp. and its American development partner lower Tuesday, but neither company indicated it was giving up on the drug....More